NCT00500006 2015-01-30A Phase I Dose Escalation Combination Study in Patients With Chronic Myelogenous Leukemia (CML) and Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)(0457-009)(TERMINATED)Merck Sharp & Dohme LLCPhase 1 Terminated3 enrolled